Cannabis Central: Pure-Play Pot Stock Index Advanced On Monday

The munKNEE.com Pot Stock Index of the 25 pure-play* cannabis stocks that trade for more than US$1/share advanced 2.1% following a 4.2% decline on Friday. 13 constituents advanced, 9 declined and 3 had no change in price. The details are as follows:

4 constituents advanced by 5% or more namely:

1. Medicine Man (SHWZ) +7.9% on top of +5.8% last Friday
2. Planet 13 (PLNHF) +7.4%
3. Curaleaf (CURLF) +6.0%
4. AYR (AYRSF) +5.7%

9 other constituents advanced and 3 had no change in price.

Only 1 constituent declined by 5% or more, namely:

• Avicanna (AVCNF) -7.6% vs. +11.9% last Friday and +28.2% for the week.

8 other constituents declined.

The constituents operate in 4 categories based on their primary area of focus in the cannabis industry and the constituents within each category are identified below with how each of the categories did:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category consists of 21 companies that grow, process, and sell cannabis and hemp flower and related products and it advanced 2.1% following a 4.4% decline on Friday.
   • the 7 constituents that are Canadian Licensed Producers (LPs) advanced 1.9%, on average, vs. a 2.1% decline Friday.
     • ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY
   • the 12 constituents that are U.S. Multi-State Operators (MSOs) advanced 2.8% on average, vs. a 5.8% decline on Friday.
     • ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; JUSHF; PLNHF; SHWZ; TRSSF; TCNNF and HRVSF
   • the 2 MSO constituents that are only involved in the seed-to-sale of CBD from hemp declined 0.8%, on average, on top of a 3.3% decline on Friday.
     • CWBHF and YCBD
2. The Extraction Category consists of companies focused on the extraction of cannabis compounds and their infusion into consumer products and it declined 0.5% on top of a 3.8% decline on Friday.
   • the 2 constituents in this category are NEPT and VLNCF
3. The Consumption Devices Category consists of companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers. Its price remained unchanged.
   • the 1 constituent in this category is GNLN
4. The Biotechnology Category consists of pharmaceutical companies marketing new drugs and products utilizing cannabinoids and the category declined 7.6% after having advanced 11.9% on Friday, +3.5% on Thursday, +3.6% on Wednesday, +4.6% on Tuesday and +2.8% on Monday.
   • the 1 constituent in this category is AVCNF

*The 25 pure-play constituents in the munKNEE.com Pot Stock Index are just that - pure - deriving 100% of their revenue from the sale of recreational and medicinal cannabis products and consumption devices to reflect the true health of the marijuana industry in the U.S. and Canada. As a result the PSI excludes 12 "wanna-be" companies often included in marijuana ETFs and industry tracking indices (see list of companies here).